Compare Dyne Therapeutics Inc. Common Stock (DYN) vs Western Digital Corp (WDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dyne Therapeutics Inc. Common Stock vs Western Digital Corp — how do they compare? Dyne Therapeutics Inc. Common Stock trades at $15.06 (market cap $2.86B), while Western Digital Corp trades at $350 (market cap $142.51B). The key difference: Western Digital Corp is far larger — about 49.8× Dyne Therapeutics Inc. Common Stock's market cap, and Western Digital Corp pays a 0.16% dividend while Dyne Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dyne Therapeutics Inc. Common Stock for 0 Days and Western Digital Corp for 38 Days on average.
| DYN | WDC | |
|---|---|---|
Market Cap | $2.86B | $142.51B |
Volume | 3,341,579 | 12,354,354 |
Sector | Health | Technology |
52-Week High | $26.78 | $746.23 |
52-Week Low | $14.60 | $120.44 |
Typical Hold Time | 0 Days | 38 Days |
Enterprise Value | $2.18B | $141.98B |
Dividend Yield | — | 0.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dyne Therapeutics (DYN) trades at $15.30, down 4.14% on the day, reflecting recent volatility amid mixed clinical trial news. The stock is in a neutral technical position with immediate support at $15 and resistance at $16. Fundamentally, the company is a clinical-stage biotech with no revenue, reporting a net loss of $446.21M in 2025, but maintains strong analyst support with an 85.7% buy rating and a $35.20 consensus price target. Recent news highlights progress in Phase 1/2 trials for neuromuscular diseases and a $375M public offering in July 2026 to fund development.
The investment case hinges on clinical success, offering significant upside to the price target, but carries high risk due to pre-revenue status, dependence on trial outcomes, and negative cash flow from operations. Investor sentiment is cautiously optimistic, buoyed by analyst confidence, though volatility from sector-specific news remains a near-term challenge.
Western Digital (WDC) trades at $364.10, down 5.9% amid concerns over increased competition after Toshiba's plans to expand AI storage production. The stock shows strong fundamentals with recent earnings beats (Q4 2025-Q2 2026) and robust profitability (net margin 71.97%, ROE 131.02%). Technical indicators are mixed with bearish moving averages but oversold RSI signals. Analyst consensus remains strongly bullish with 72% buy ratings and $643 price target.
WDC presents a compelling value opportunity with attractive valuation multiples (P/E 14.14) and strong AI-driven growth prospects, though near-term pressure from competitive threats and market volatility requires careful monitoring. The company's leadership in high-capacity drives for AI infrastructure supports long-term upside potential despite recent selloff.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dyne Therapeutics Inc. Common Stock
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company developing therapeutics for genetically driven neuromuscular diseases, including Duchenne muscular dystrophy and myotonic dystrophy type 1, with additional preclinical programs for facioscapulohumeral muscular dystrophy and Pompe disease.
Read more on DYN →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
